Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca India, Indian Academy of Paediatrics unite to raise awareness on respiratory syncytial…
This collaboration aims to focus on education, early detection and spreading awareness among healthcare professionals, parents,…
Aptar pharma announces expansion of new facility in Taloja
With the new facility, Aptar aims to meet the region’s growing needs by adding 4400 m2 of manufacturing footprint
CAR T cell therapies to promote drug-free remission in lupus care
BMS’s CC-97540 and Cabaletta Bio’s CABA-201 highlight CAR T’s potential to achieve lasting drug-free remission, marking a…
UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
17th edition of CPHI & PMEC India expo to be held from Nov 26-28, 2024
As a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will showcase the pharmaceutical…
Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of…
Rice University’s ROGUE device implants a ‘living pharmacy’ to combat diabetes and obesity
The ROGUE device is significant for countries like India as it offers a ‘living pharmacy’ that produces and adjusts diabetes…
STEERLife and Callidus Research Laboratories partner to accelerate drug development
The collaboration combines STEERLife's advanced hot melt extrusion (HME) and continuous processing technologies with Callidus'…
ALK licenses rights to neffy, an adrenaline nasal spray for emergency treatment of anaphylaxis
ALK also gains rights to future indications, including acute urticaria flares (in development)
Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents: GlobalData
The 7MM pipeline in Parkinson’s disease shifts focus to neuroprotective and disease-modifying therapies, aiming to address unmet…